Trial NCT05494619

View at ClinicalTrials.gov 
Org. Study IDs: BN43118
Secondary IDs: 2021-002968-49

Last trial update was posted on 2022-12-15

MeSH Interventions

Antibodies Immunoglobulins Immunoglobulins, Intravenous Rho(D) Immune Globulin gamma-Globulins

MeSH Conditions

Guillain-Barre Syndrome Syndrome

Other Conditions

Guillain-Barré Syndrome

Stopping Reasons

This study has been withdrawn due to an internal decision. The decision was not due to any safety concerns with study drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID